期刊
EMBO REPORTS
卷 6, 期 6, 页码 551-556出版社
WILEY
DOI: 10.1038/sj.embor.7400418
关键词
DNA interstrand crosslinks; DNA repair; mismatch repair; psoralen
资金
- NCI NIH HHS [R01 CA093729, P01 CA097175, CA97175, CA93729] Funding Source: Medline
- NIEHS NIH HHS [P30 ES007784, ES07784] Funding Source: Medline
DNA interstrand crosslinks (ICLs) present formidable blocks to DNA metabolic processes and must be repaired for cell survival. ICLs are induced in DNA by intercalating compounds such as the widely used therapeutic agent psoralen. In bacteria, both nucleotide excision repair (NER) and homologous recombination are required for the repair of ICLs. The processing of ICLs in mammalian cells is not clearly understood. However, it is known that processing can occur by NER, which for psoralen ICLs can be an error-generating process conducive to mutagenesis. We show here that another repair pathway, mismatch repair (MMR), is also involved in eliminating psoralen ICLs in human cells. MMR deficiency renders cells hypersensitive to psoralen ICLs without diminishing their mutagenic potential, suggesting that MMR does not contribute to error-generating repair, and that MMR may represent a relatively error-free mechanism for processing these lesions in human cells. Thus, enhancement of MMR relative to NER may reduce the mutagenesis caused by DNA ICLs in humans.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据